companydata.dkPHARMA EVIDENCE ApS: Financial statements 2016
CVR: 34586519
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -28,318 and a net result of DKK -47,525 compared with DKK -153,811 the year before. Equity amounted to DKK 25,847. The solvency ratio was 25.3%.
- Gross Profit
- -28,318 kr.
- Profit/Loss
- -47,525 kr.
- Equity
- 25,847 kr.
- Total Assets
- 102,058 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -28 t. | -48 t. | 26 t. | - |
| 2015 | - | 255 t. | -154 t. | 73 t. | - |
| 2014 | - | 1.3 mio. | -237 t. | 227 t. | - |
| 2013 | - | 892 t. | 54 t. | 464 t. | - |
| 2012 | - | 868 t. | -448 t. | 410 t. | - |
How creditworthy is PHARMA EVIDENCE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
PHARMA EVIDENCE ApS has published its annual report for 2015. Gross profit came to DKK 254,815, and the net result was DKK -153,811.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 2 employees. In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity amounted to DKK 134,401.